Wilmington Savings Fund Society FSB Sells 673 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Wilmington Savings Fund Society FSB reduced its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 35.4% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 1,227 shares of the biotechnology company’s stock after selling 673 shares during the period. Wilmington Savings Fund Society FSB’s holdings in Axon Enterprise were worth $729,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in the company. Groupama Asset Managment bought a new stake in shares of Axon Enterprise in the third quarter valued at approximately $200,000. Massachusetts Financial Services Co. MA purchased a new position in Axon Enterprise in the 3rd quarter valued at approximately $120,553,000. International Assets Investment Management LLC bought a new stake in Axon Enterprise during the 3rd quarter valued at $871,860,000. Westfield Capital Management Co. LP boosted its holdings in shares of Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after acquiring an additional 127,769 shares during the period. Finally, Assenagon Asset Management S.A. grew its position in shares of Axon Enterprise by 328.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after purchasing an additional 111,405 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Axon Enterprise

In related news, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the sale, the director now directly owns 24,259 shares in the company, valued at $15,518,239.71. The trade was a 3.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, President Joshua Isner sold 1,291 shares of the firm’s stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total value of $829,377.13. Following the transaction, the president now directly owns 181,892 shares of the company’s stock, valued at $116,852,877.56. This represents a 0.70 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 8,711 shares of company stock worth $5,631,561. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Stock Down 0.2 %

Shares of Axon Enterprise stock opened at $677.85 on Tuesday. The company’s 50 day moving average price is $624.26 and its 200-day moving average price is $498.90. Axon Enterprise, Inc. has a 52-week low of $255.68 and a 52-week high of $698.67. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a market capitalization of $51.69 billion, a price-to-earnings ratio of 175.16, a P/E/G ratio of 6.79 and a beta of 1.05.

Analyst Ratings Changes

AXON has been the subject of several analyst reports. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Needham & Company LLC boosted their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. TD Cowen initiated coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective for the company. Finally, Northland Securities upped their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus price target of $542.15.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.